Latest Posts › Trump Administration

Share:

Coronavirus: The Hill and the Headlines, November 2020 # 3

In Washington: The federal government’s role in physically distributing COVID-19 vaccines remains unclear. President Trump said last month that the military would distribute vaccines. But a spokesman for Operation Warp...more

Coronavirus: The Hill and the Headlines, November 2020 # 2

In Washington: Senate Majority Leader Mitch McConnell (R-KY) outlined a busy lame-duck session agenda Wednesday, saying he wants another coronavirus relief bill by the end of the year and a spending bill by the December 11...more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

In Tuesday's Report: FDA lists essential medicines and medical countermeasures, Trump plans health official replacement, FDA expands remote monitoring exemption list, WHO director self-quarantines, and other U.S. White House...more

Coronavirus: The Hill and the Headlines, November 2020

In Washington: Senate Majority Leader Mitch McConnell (R-KY) and House Speaker Nancy Pelosi (D-CA) who have not agreed on much related to the COVID-19 response in recent months, differed again Friday when asked about when...more

Coronavirus: The Hill and the Headlines, October 2020 # 20

In Washington: The possibility of a lame-duck session coronavirus relief deal remains shaky. House Speaker Nancy Pelosi (D-CA) holds out hope, telling reporters Thursday that she wants “as clean a slate as possible” for an...more

Coronavirus: The Hill and the Headlines, October 2020 # 19

In Washington: House Speaker Nancy Pelosi (D-CA) in a Thursday morning letter to Treasury Secretary Steven Mnuchin pressed the White House for a response to the Democrats' latest coronavirus relief package proposal....more

Coronavirus: The Hill and the Headlines, October 2020 # 18

In Washington: The Trump administration will pay Eli Lilly $375 million to supply 300,000 doses of its experimental antibody drug to treat COVID-19, the Department of Health and Human Services said Wednesday. If the Food and...more

Coronavirus: The Hill and the Headlines, October 2020 # 17

In Washington: White House communications director Alyssa Farah said Tuesday that the White House still hopes for a coronavirus relief package, probably post-election. Speaking on Fox & Friends, Farah said President Trump...more

Coronavirus: The Hill and the Headlines, October 2020 # 16

In Washington: In a letter to colleagues on Monday, House Speaker Nancy Pelosi (D-CA) said the White House has refused to sign on to Democratic lawmakers’ plan for a coronavirus testing strategy, despite earlier public...more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

In Tuesday's Report: FDA warns over drug misbranded as COVID-19 treatment; podcast discusses Trump's "Buy American" executive order; an op-ed on the importance of protecting biomedical innovation; HHS sees high level...more

Coronavirus: The Hill and the Headlines, October 2020 # 15

In Washington: After several consecutive days of talks between House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin it appears increasingly likely that Congress will have to wait to consider any COVID-19...more

Coronavirus: The Hill and the Headlines, October 2020 # 13

In Washington: House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin continued negotiations on a fourth COVID-19 stimulus bill on Wednesday. Pelosi’s spokesman Drew Hammill sent a series of Tweets...more

Coronavirus: The Hill and the Headlines, October 2020 # 12

In Washington: Tuesday afternoon, House Speaker Nancy Pelosi (D-CA) said Democrats and the White House have moved closer to a deal on a fourth COVID-19 stimulus relief bill ahead of her latest call with Treasury Secretary...more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

Tuesday, 20 October 2020 - President Trump’s executive order on essential medicines aims to encourage pharmaceutical companies to bring their manufacturing back to the U.S. But it may also have unintended consequences for...more

Coronavirus: The Hill and the Headlines, October 2020 #11

In Washington: House Speaker Nancy Pelosi (D-CA) set a Tuesday deadline for her and Treasury Secretary Steven Mnuchin to reconcile significant policy disputes if they want to pass a coronavirus relief bill before Election...more

Coronavirus: The Hill and the Headlines, October 2020 # 10

In Washington: State public health officials are urging Congress to provide at least $8.4 billion in emergency funding for distributing a coronavirus vaccine, warning that they lack enough money to carry out the immense...more

Coronavirus: The Hill and the Headlines, October 2020 # 9

In Washington: President Trump said Thursday that he is willing to go higher than his current $1.8 trillion offer for the next coronavirus stimulus package as negotiations continue. “Go big or go home,” Trump told Fox...more

Coronavirus: The Hill and the Headlines, October 2020 # 8

In Washington - Secretary Steven Mnuchin and Speaker Nancy Pelosi spoke for an hour Wednesday morning and plan to speak again tomorrow. Mnuchin says they continue to “make progress” while Pelosi’s spokesperson says the...more

Coronavirus: The Hill and the Headlines, October 2020 # 7

In Washington: Hopes for a quick resolution to the stimulus talks continue to fade though House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin continue talking this week to try and bridge the gap between...more

Coronavirus: The Hill and the Headlines, October 2020 # 6

In Washington: On a conference call Saturday, Senate Republicans relayed their objections to another enormous coronavirus relief package to party leaders and top Trump officials. Members cited that Republican voters have...more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

Tuesday, 13 October 2020 - The Hogan Lovells Government Relations and Public Affairs group is tracking all of the latest developments in the U.S. Congress and relevant news stories. President Trump and his aides on Friday...more

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time. ...more

Coronavirus: The Hill and the Headlines, October 2020 # 3

In Washington: As planned, the House of Representatives is on recess through the election but Democratic leadership may call members back for a potential vote on a coronavirus stimulus bill. Senate Majority Leader Mitch...more

58 Results
 / 
View per page
Page: of 3

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide